Skip to main content
AdChoices
Canada
World
Business
Investing
Watchlist
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Podcasts
Biotechnology
Follow
You must be logged in to follow.
Log In
Create free account
Latest
investment ideas
Deals, data buzz could help biotech shares exit Wall Street’s ‘no man’s land’
October 15, 2021
report on business
Field Trip Health raises largest financing in Canada for a psychedelics company
March 17, 2021
report on business
B.C.’s Eupraxia Pharmaceuticals sees lacklustre trading debut
March 9, 2021
advisor etfs
Why the nascent psychedelics industry is getting investors’ attention
March 2, 2021
report on business
First TSX-only biotech IPO in 18 years set for next week as Eupraxia closes books on $41-million offering
March 1, 2021
report on business
Vancouver biotech Notch Therapeutics raises US$85-million in venture funding
February 10, 2021
report on business
TMX CEO aims to encourage small biotech companies to list in Canada
February 9, 2021
report on business
RBC taps into biotech surge, investing in new Lumira venture fund
February 1, 2021
report on business
Vancouver’s Khosrowshahi family to launch US$400-million pharma IPO, capitalizing on biotech craze
January 25, 2021
report on business
Rare milestone approaches for Canadian biotech sector as Aurinia awaits FDA OK to sell new drug
January 17, 2021
report on business
AbCellera Biologics’s billionaire boss planning hiring spree in Vancouver hometown after record-setting IPO
January 7, 2021
opinion
What Canada needs to do to build a world-class biotech sector
Roberto Bellini
December 23, 2020
report on business
AbCellera closes record biotech IPO as underwriters exercise option to buy shares; total proceeds US$555.5-million
December 16, 2020
number cruncher
Which of these top 10 Canadian biotech stocks are undervalued?
December 14, 2020
international business
AstraZeneca shares fall as investors react to $39-billion Alexion acquisition
December 14, 2020
international business
AstraZeneca to buy U.S. drugmaker Alexion for $39-billion to expand in immunology
December 12, 2020
report on business
Vancouver’s AbCellera more than doubles IPO target size, headed for biggest debut on record for Canadian biotech
December 7, 2020
investment ideas
Cowen’s CEO sees gains in biotech, helped by easier access to cash
December 2, 2020
report on business
Booming Canadian biotech sector on track for record year after raising $1-billion in venture capital so far in 2020
November 26, 2020
report on business
Peter Thiel joins board of B.C. antibody therapy developer AbCellera in advance of expected IPO
November 19, 2020
report on business
Canada’s Pascal Biosciences partners with U.S. firm to test cannabis-based cancer therapy
September 14, 2020
report on business
Antibody therapy developer AbCellera hires banks for U.S. IPO, sources day
September 11, 2020
international business
Sanofi snags another U.S. biotech firm with $3.7-billion Principia deal
August 17, 2020
international business
CureVac doesn’t rule out accelerated approval for COVID-19 vaccine
August 16, 2020
advisor mutual funds
Active management finds niche in post-pandemic market
August 4, 2020
report on business
Vancouver COVID-19 therapy developer AbCellera eyeing potential IPO as early as fall
July 27, 2020
stars and dogs
The Globe’s stars and dogs for the week
July 17, 2020
letters
July 9: ‘The government of the people, by Justin Trudeau, for the people.’ Readers take a closer look at the WE Charity contract, plus other letters to the editor
July 9, 2020
streetwise newsletter
Streetwise newsletter: Best reads of the week
July 3, 2020
report on business
Biotech blind spot: How Canada’s big investors missed the boom happening right now
July 3, 2020
inside the market
Top Canadian biotech investor on the firms most likely to turn COVID-19 drug trials into treatments and when a vaccine may arrive
July 3, 2020
stars and dogs
The Globe’s stars and dogs for the week
July 3, 2020
science
BioNTech and Pfizer’s COVID-19 vaccine shows potential in human trial
July 1, 2020
european business
Temasek-led investor group makes $250-million vaccine bet on Germany’s BioNTech
June 29, 2020
technology
Hamilton biotech Fusion sets IPO price at $17 a share for Friday debut on Nasdaq
June 25, 2020